Objectives
To study contemporary popliteal artery aneurysm (PA) repair.
Methods
Vascunet is a collaboration of population-based registries in 10 countries: eight had data on PA repair (Australia, Finland, Hungary, Iceland, New Zealand, Norway, Sweden, and Switzerland).
Results
From January 2009 until June 2012, 1,471 PA repairs were registered. There were 9.59 operations per million person years, varying from 3.4 in Hungary to 17.6 in Sweden. Median age was 70 years, ranging from 66 years in Switzerland and Iceland to 74 years in Australia and New Zealand; 95.6% were men and 44% were active smokers.
Elective surgery dominated, comprising 72% of all cases, but only 26.2% in Hungary and 39.7% in Finland, (p < .0001). The proportion of endovascular PA repair was 22.2%, varying from 34.7% in Australia, to zero in Switzerland, Finland, and Iceland (p < .0001). Endovascular repair was performed in 12.2% of patients with acute thrombosis and 24.1% of elective cases (p < .0001). A vein graft was used in 87.2% of open repairs, a synthetic or composite graft in 12.7%.
Follow-up was until discharge or 30 days. Amputation rate was 2.0% overall: 6.5% after acute thrombosis, 1.0% after endovascular, 1.8% after open repair, and 26.3% after hybrid repair (p < .0001). Mortality was 0.7% overall: 0.1% after elective repair, 1.6% after acute thrombosis, and 11.1% after rupture.
Conclusions
Great variability between countries in incidence of operations, indications for surgery, and choice of surgical technique was found, possibly a result of surgical tradition rather than differences in case mix. Comparative studies with longer follow-up data are warranted.
Keywords
What this paper adds
Popliteal artery aneurysm is the most common peripheral aneurysm, yet data on this disease are limited. The great differences between countries regarding the treatment of popliteal artery aneurysm, found in this descriptive study, are thought-provoking and will, hopefully, result in more focused research in the future. The vascular registries need to be revised and collect more precise data on pathology, indication, treatment and outcome in the future, and those variables described herein.
Introduction
Popliteal artery aneurysm (PA) is the most commonly treated extracranial aneurysm outside of the aorta, and thus constitutes an important clinical problem. Despite this, the disease is rare and difficult to study with a scientific approach. In Sweden, between 1994 and 2001, the incidence of PA repair was only 8.3 per million person years.
1
Consequently, most previous reports on PA are case series from single institutions.2
, 3
, 4
, 5
One prospective multi-centre study was published from the UK Joint Vascular Research Group in 1994.6
Two large observational studies, based on prospectively reported data collected from vascular centres in Sweden1
and the USA,7
and supplemented by review of the patient's records, were published in 2007–2008. The Swedish study also re-examined patients a median 7 years after PA repair, and reported a very high frequency of multiple aneurysm disease: abdominal aortic aneurysm (AAA), bilateral PAs, and of other extracranial peripheral aneurysms.8
In recent years, many investigators have reported single centre experiences on an increased use of endovascular repair of PA, although one of the pioneers in this treatment, the Groningen group, reported a high frequency of stent-fractures after endovascular repair.
9
Galiñanes et al.10
recently reported an investigation on patients operated on for lower extremity artery aneurysms, predominantly, but not exclusively, PAs, from the Medicare & Medicaid database 2005–2007. A total of 2,962 patients was identified and endovascular interventions significantly increased over this short timespan, from 12% to 24%. No data on the use of endovascular PA repair in large populations outside of the USA exist.Vascunet is a collaboration of population-based registries in Europe, Australia, and New Zealand that started in 1997.
11
At present, 10 countries contribute to the common database, and previous reports on AAA repair,12
carotid endarterectomy,13
, 14
and lower limb bypass surgery15
have been published. The aim of this investigation was to explore the contemporary treatment of PA in the collaborating countries.Methods
In May 2012 the 10 collaborating national and regional registries were invited to participate, and a common set of variables was agreed upon. Denmark was not able to distinguish PA from other peripheral aneurysms of the lower limb, that is, from femoral aneurysms in their databases, and could therefore not participate in this investigation. The UK did not have any data on endovascular repair, and also had difficulties in distinguishing PA from other peripheral aneurysms of the lower limb. Finland submitted data from the Helsinki and Vaasa regions only. In all, data from eight countries were included.
A common dataset was agreed upon (Table 1), that is, participant registries recoded their data to conform to this common format. Not all registries could provide all the variables (see ‘Results’). A hybrid procedure was defined as an open surgical and an endovascular operation being performed simultaneously. The registries in Finland, Iceland, Norway, and Sweden register follow-up at 30 days and the others at discharge.
Table 1Popliteal aneurysm data dictionary.
Fields | Description on form | Possible responses | Format of field |
---|---|---|---|
Country | Country | AUS, NZ, UK, Sweden, DM, Finland, Hungary, Italy, Switzerland | Text |
Hospital ID | Hospital dode or identifier | Number/letter combination | Text |
Patient age | Age of patient at the time of surgery | Whole number | Integer |
Patient ID | Patient identifier (allocated by country and anonymised) | Number/letter combination | Text |
Gender | Sex | Male, female | 1 = male, 2 = female |
Admission date | Date of admission | Date | dd/mm/yyyy |
Admission mode | Mode of admission | Elective, emergency | 1 = elective, 2 = emergency |
Diabetes | Diabetes | Yes or no | 0 = no, 1 = yes |
Cardiac history | Cardiac history—any IHD or CCF | Yes or no | 0 = no, 1 = yes |
Current smoker | Current smoker (within 2 months) | Yes or no | 0 = no, 1 = yes |
Pulmonary history | Symptomatic lung disease | Yes or no | 0 = no, 1 = yes |
Cerebrovascular event | Previous stroke or TIA | Yes or no | 0 = no, 1 = yes |
History | |||
Hypertension history | Hypertension | Yes or no | 0 = no, 1 = yes |
Preoperative data | |||
Indication | Indication for surgery | Elective, emergency thrombosis, emergency rupture | 1 = elective, 2 = emergency thrombosis, 3 = emergency rupture |
Side of operation | Side of symptomatic leg | Right or left | 1 = right, 2 = left |
ABI | Ankle brachial pressure index | Number to 1 decimal point | Number (0–1.5) |
Operative data | |||
Operation date | Date of operation | Date dd/mm/yyyy | |
Procedure | Endovascular or open surgery | Endovascular, open, hybrid | 1 = endovascular, 2 = open surgery, 3 = hybrid |
Access route | Access route | Medial, dorsal, other, endovascular | 1 = medial, 2 = dorsal, 3 = other, 4 = endovascular |
Proximal anastomosis site | Anatomic site of proximal anastomosis | Iliac, femoral, popliteal, other | 1 = iliac, 2 = femoral, 3 = popliteal, 4 = other |
Distal anastomosis site | Anatomic site of distal anastomosis | Popliteal above knee, popliteal below knee, crural, pedal, other | 1 = popliteal above knee, 2 = Popliteal below knee, 3 = crural, 4 = pedal, 5 = other |
Graft type | Type of graft | Vein, synthetic, composite | 1 = Vein, 2 = synthetic, 3 = composite |
Additional open procedure | Additional open procedure at time of surgery | Yes or no | 0 = no, 1 = yes |
AEP | AEP at time of surgery | Yes or no | 0 = no, 1 = yes |
Preoperative thrombolysis | Preoperative thrombolysis | Yes or no | 0 = no, 1 = yes |
Perioperative thrombolysis | Perioperative thrombolysis | Yes or no | 0 = no, 1 = yes |
Follow-up (in hospital or 30 days) | |||
Discharge date | Date of discharge | Date dd/mm/yyyy | |
Wound complication (WC) | WC leading to surgical intervention | Yes or no | 0 = no, 1 = yes |
Haemorrhage | Reoperation for haemorrhage | Yes or no | 0 = no, 1 = yes |
Compartment syndrome (CS) | CS requiring fasciotomy | Yes or no | 0 = no, 1 = yes |
Graft patent at discharge | Graft patent at discharge | Yes or no | 0 = no, 1 = yes |
Graft patent at 30 days | Patent graft at 30 days | Yes or no | 0 = no, 1 = yes |
Amputation | Amputation at ankle or higher on ipsilateral side | Yes or no | 0 = no, 1 = yes |
ABI | Ankle brachial pressure index | Number to 1 decimal | Number (0–1.5) |
Acute coronary event | Acute coronary syndrome, MI, serious arrhythmia, cardiac failure | Yes or no | 0 = no, 1 = yes |
Major stroke | Major stroke | Yes or no | 0 = no, 1 = yes |
Died within 30 days of surgery | Deceased at 30 days | Yes or no | 0 = no, 1 = yes |
Date of death | Date of death (if known) | Date dd/mm/yyyy | |
Data based on hospital discharge or 30 days? | Follow-up time | Discharge or 30 days | 1 = discharge, 2 = 30 days |
Note. ID = identification; IHD = ischaemic heart disease; CCF = congestive cardiac failure; TIA = transient ischaemic attack; AUS = Australia; NZ = New Zealand; DM = Denmark; AEP = additional endovascular procedure; MI = myocardial infarction.
Statistical comparisons were performed with Fisher's exact test for dichotomous variables (such as amputations), when two groups were compared. When multiple countries were compared, either analysis of variance or Pearson's chi-square test with different degrees of freedom were used as appropriate.
Results
The operations were performed between January 2009 and June 2012, and a total of 1,471 PA repairs were included in the common database. Time periods and catchment areas differed, as described in Table 2. Most repairs (77.1%) were performed between 2010 and 2011, 19.1% during 2009 and only 3.8% during 2012. The largest number of cases was submitted from Sweden (495; 34%) and Australia (441; 30%); the remaining countries/regions constituted 36% of the database. The overall number of operations per million person years was 9.59, but varied considerably, from 3.4 in Hungary to 17.6 in Sweden.
Table 2Participating countries, time periods, population covered, number of operations, and incidence of operations per million inhabitants.
Country | Time period | Population millions | Number of operations | Operations/million inhabitants/year |
---|---|---|---|---|
Australia | 2010–2011 | 22.5 | 441 | 9.9 |
Finland (Helsinki) | 2009–2011 | 1.37 | 58 | 13.9 |
Hungary | 2009–2012 | 9.96 | 103 | 3.4 |
Iceland | 2009–2011 | 0.35 | 6 | 5.7 |
Norway | 2009–2012 | 4.7 | 188 | 11.9 |
New Zealand | 2010–2012 | 4.4 | 93 | 7.0 |
Sweden | 2009–2011 | 9.5 | 495 | 17.6 |
Switzerland | 2009–2011 | 5.6 | 87 | 5.2 |
All | 2009–2012 | 58.4 | 1471 | 9.59 |
Note. The other countries included national data.
a Finland included defined regional data.
b The countries including 2012 only included the first 3–6 months of that year.
c The Swiss registry covers approximately 70% of the entire population of eight million inhabitants.
The median age of the patients was 70 years, ranging from 66 years in Switzerland and Iceland to 74 years in Australia and New Zealand. As expected, most patients (95.6%) were men. The 64 women had a median age of 73.5 years, which was not significantly older than the men (p = .46). The small number of women reduced the power when analysing gender differences. The proportion of patients ≥80 years of age was 19.2% among men and 18.8% among women.
The risk factors diabetes, cardiac history, pulmonary history and hypertension were registered in almost 100% of cases, cerebrovascular event in 54.8% and smoking history in 91.5%. Overall and national prevalences of the risk factors are given in Table 3; differences between countries were all statistically significant (p < .0001).
Table 3Prevalence of preoperative risk factors. All values are given as percentages.
Risk factor | All | Aus | Fin | Hun | Ice | Nor | NZ | Swe | Swi | p |
---|---|---|---|---|---|---|---|---|---|---|
Cardiac history | 37.1 | 50.1 | 48.3 | 39.8 | 50.0 | 41.5 | 37.6 | 23.4 | 27.6 | <.0001 |
Pulmonary history | 14.0 | miss | 15.5 | 19.4 | 0.0 | 15.4 | miss | 9.5 | 10.3 | <.0001 |
Hypertension | 72.4 | 83.2 | 77.6 | 86.4 | 66.7 | 58.0 | 75.3 | 62.2 | 83.9 | <.0001 |
Cerebrovascular event | 9.0 | miss | 10.3 | miss | 0.0 | 12.2 | miss | 8.7 | 4.6 | <.0001 |
Diabetes | 16.2 | 16.6 | 20.7 | 26.2 | 33.3 | 16.0 | 12.9 | 13.3 | 19.5 | <.0001 |
Current smoking | 44.0 | 76.2 | 46.3 | 47.6 | 16.7 | 37.2 | 8.6 | 21.4 | 57.5 | <.0001 |
Note. All = average proportion of all countries with data; Aus = Australia; Fin = Finland; Hun = Hungary; Ice = Iceland; Nor = Norway, NZ = New Zealand; Swe = Sweden; Swi = Switzerland; miss = missing data in this particular registry.
a p-Values refer to differences between countries.
The indication for treatment varied considerably between the countries (p < .0001) (Table 4). Elective surgery dominated in most countries, accounting overall for 72% of cases, but it was as low as 26.2% in Hungary and 39.7% in Finland.
Table 4Indications for treatment of popliteal artery aneurysm in the different countries studied.
Country | All (n) | Elective surgery (n) | % | Emergency surgery (n) | % |
---|---|---|---|---|---|
Australia | 441 | 380 | 86.2 | 61 | 13.8 |
Finland (Helsinki) | 58 | 23 | 39.7 | 35 | 60.3 |
Hungary | 103 | 27 | 26.2 | 76 | 73.8 |
Iceland | 6 | 6 | 100 | 0 | 0.0 |
Norway | 188 | 151 | 80.3 | 37 | 19.7 |
New Zealand | 93 | 60 | 64.5 | 33 | 35.5 |
Sweden | 495 | 370 | 74.7 | 125 | 25.3 |
Switzerland | 87 | 42 | 48.3 | 45 | 51.7 |
All | 1,471 | 1,059 | 72.0 | 412 | 28.0 |
Note.
a Most emergency operations were performed for acute thrombosis and/or embolism, but 27 patients (1.8%) were operated on for rupture (six in Australia, 11 in Norway, and 10 in Sweden).
Endovascular repair was performed in 326 patients 22.2% (endovascular only in 307, hybrid operations in 19) (Table 5). The proportion of endovascular repair varied considerably from 34.7% in Australia to zero in Switzerland, Finland, and Iceland (p < .0001).
Table 5The proportion of open and endovascular surgery for popliteal artery aneurysm in the different countries studied.
Country | All repairs | Open repair (n) | Endovascular repair (n) | Endovascular repair (%) |
---|---|---|---|---|
Australia | 441 | 288 | 153 | 34.7 |
Finland (Helsinki) | 58 | 58 | 0 | 0.0 |
Hungary | 103 | 97 | 6 | 5.8 |
Iceland | 6 | 6 | 0 | 0.0 |
Norway | 188 | 171 | 17 | 9.0 |
New Zealand | 93 | 89 | 4 | 4.3 |
Sweden | 495 | 349 | 146 | 29.5 |
Switzerland | 87 | 87 | 0 | 0.0 |
All | 1,471 | 1,145 | 326 | 22.2 |
Note.
a Sixteen hybrid operations in Sweden and three in Hungary were considered endovascular in this analysis.
The choice of technique was also dependent on the indication. Endovascular technique was performed in only 12.2% of those operated on for emergency thrombosis compared with 24.1% of the elective cases (p < .0001). Of the 19 hybrid cases, 15 (79%) were performed for emergency thrombosis. Four of the 18 patients treated for rupture (22%) were operated on with an endovascular technique. There was a higher proportion of endovascular repair among women (34.4%) than among men (21.6%) (p = .031). Among patients ≥80 years of age, however, a higher proportion was treated with endovascular repair among men (39.6%) compared with women (25.0%), p = .031.
All countries except Hungary registered the graft used during open repair. Among the 988 patients, 862 (87.2%) were operated on with a vein, 116 with a synthetic graft (11.7%), and 10 (1%) with a composite graft. The only country that registered the diameter of the PAs was Norway. The median diameter was 30 mm (range 10–90 mm), and only 3/168 patients (1.8%) had a diameter <15 mm.
The inflow and outflow anatomy was available in 79.5% and 80.3% of the procedures. The femoral artery dominated (51.4%), followed by the popliteal artery (24.8%), and other inflow, such as a graft in 2.9%. The outflow vessel was most frequently the popliteal artery below the knee (58.7%), followed by a crural vessel (15.5%), the popliteal artery above the knee (4.6%), and a pedal vessel (0.3%).
Only three of the countries registered the type of open surgical approach: Finland, Norway (Bergen County), and New Zealand. Among the 169 patients operated on in those countries, 145 (85.8%) were operated on with an open medial approach, 15 (8.9%) with an open posterior approach, and nine (5.3%) with endoPA repair.
Sixty-five cases of thrombolysis were registered: 56 from Sweden, five from Norway, three from Finland, and one from Hungary. It was impossible, however, to distinguish if those were pre- or perioperative procedures, and many preoperative thrombolysis procedures may have been registered as separate procedures.
The amputation rates in the participating countries are given in Table 4. The frequencies of major complications, including death and amputation, were difficult to compare between countries, as some countries only reported events during the first hospitalisation episode and others at follow-up 30 days after surgery. Overall, postoperative haemorrhage was registered in 61/1109 (5.5%), compartment syndrome in 13/782 (1.7%), and other wound complications in 129/1115 (11.6%). Acute coronary events were registered in 10/1108 (0.9%) and stroke in 5/853 (0.6%). One year follow-up data could be provided by few of the registries, and even in those was not complete. In Swedvasc, for instance, 2/3 of the patients had 1 year follow-up data. We therefore decided not to analyse those data. When comparing the three countries that had a high proportion of emergency repair (Finland, Hungary, and Switzerland), they had an amputation rate of 3.8% (9/239) compared to the remaining countries, which reported an amputation rate of 1.6% (20/1232; p = .040).
The overall major amputation rate was 2.0%. It differed depending on indication with amputation occurring in 6.5% after emergency procedures for thrombosis. It also differed depending on surgical technique: 1.0% after endovascular, 1.8% after open, and 26.3% after hybrid repair (p < .0001). The mortality difference between endovascular and open technique was not significant. Ten patients died (0.7%) within 30 days or within the hospital stay, depending on which registry the patients were registered in. Mortality was 0.1% after elective surgery, 1.6% after emergency procedures for thrombosis, and 11.1% after the 27 procedures for rupture.
Discussion
To our knowledge, this is the first attempt to perform a multinational epidemiological overview of the current treatment of PA. The investigation is warranted, given the background of increasing numbers of procedures, and by the introduction of endovascular techniques. The number of operations per million inhabitants per year varied considerably between countries—the difference between Hungary and Sweden was more than fivefold (Table 1). Is this variability a result of differences in prevalence of disease, different diagnostic activity, or perhaps differences in indications for treatment of identified patients? Unfortunately, the database does not contain information to answer those important questions with certainty, but there are some possible explanations that may be discussed. We know from AAA screening studies in Sweden
16
, 17
and the UK,18
, 19
as well as from epidemiological data on AAA rupture and death in Australia20
and New Zealand21
that the prevalence of AAA is falling in many of the countries included in this investigation. This fall in AAA prevalence is thought to be explained mainly by falling smoking rates.17
, 19
There is a very strong association between PA and smoking and the coexistence of AAA. As a consequence, one would expect a decrease in the incidence of PA repair, but the opposite is found in Sweden. In a previous investigation from the same Swedvasc registry 1994–2001 the incidence of PA repair was only 8.3 per million person years1
compared with 17.6 during 2009–2011—an increase of 112%.The increase in prevalence observed in Sweden could be a result of an increased awareness of the association between AAA and PA,
8
in combination with an increased detection rate of AAA in the population by screening. The screening programme in Sweden was initiated in 2006,16
and many of the screening detected AAA patients were probably screened for PA with ultrasound, as this is a routine in most Swedish hospitals, but not in the other countries participating in this investigation. There may also be national differences in how patients with acute limb ischaemia are assessed. If no ultrasound examination is performed in a patient with an acute thrombosis of the popliteal artery, an underlying PA may not be detected.The great differences in disease prevalence may also be explained by ethnicity and hereditary factors. It has been shown in AAA disease that there is a strong interaction between heredity and environment.
22
Although there are less data on patients with PA, we have reasons to believe that the same interaction is present in these patients, who often have concomitant AAA.The main risk factors for AAA, smoking, and male sex, dominate even more in the PA population. Svensjö et al.
17
reported that 33% of 373 65-year-old men screened were smokers compared to 44% in this cohort of patients with PA. In another report from Vascunet, Mani et al.12
reported that 13.3% of patients after intact AAA repair and 16.2% after ruptured AAA repair were women compared to only 4.6% in this cohort of patients with PA.Ravn et al.
23
reported that late expansion was common after open PA repair, 33% after a mean of 7.2 years, when the medial approach was used—a complication similar to type II endoleak after endovascular aneurysm repair (EVAR). This complication, that was virtually non-existent after an operation with a posterior approach, was associated with symptoms in most patients, and some even required reoperation. Unfortunately, the choice of surgical access in open surgery was reported from only three countries in this investigation, but the medial approach dominated with 85%. Several of the registries are now adding this variable to their databases, so we will know in the future if a shift in the choice of surgical access route takes place.This study focused on the definitive repair of PA. Unfortunately, we were unable to identify all the patients who first underwent intra-arterial thrombolysis, followed by definitive open or endovascular repair, and to distinguish those from patients who underwent perioperative thrombolysis. One of the effects of this kind of exercise, merging data from different registries, is that variables are added when missing and amended when necessary, thus facilitating future research. A variable indicating preoperative thrombolysis (yes/no) was added to the Swedvasc registry when registering carotid procedures 2 years ago, and is now being added also to the PA module, and if more countries join a future analysis of this data will turn possible.
The effect of preoperative thrombolysis on short- and long-term results was not possible to analyse in this database, the reason being that this intervention could be registered either as an independent operation, or as a part of the open or endovascular procedure aimed at repairing the PA. This limitation of the participating registries was highlighted by this project, and several of the registries are preparing to revise their registration to enable such an analysis in the future. This is, in fact, one of the most important results of the Vascunet collaboration, that is, that the registries are adapted and amended as a result of previous investigations.
10
, 11
, 12
, 13
, 14
, 15
Among the most interesting observations are the great differences between countries in indications for treatment and in frequency of endovascular repair. If we exclude Iceland, which is a small country in which only six patients were operated on, the proportion of elective repairs varied between 86% in Australia and only 26% in Hungary (Table 3). These differences probably reflect both the level of diagnostic activity and the therapeutic tradition, whether to treat asymptomatic patients or not, including the diameter threshold and if the presence of thrombosis in smaller aneurysms is considered an indication for surgery. Unfortunately, we only have information for the diameter of the PA from one country (Norway). That country, however, had one of the highest proportions of elective repairs (80%) and yet only 2% had a diameter <15 mm. It will be interesting to perform a study in the future to assess whether the countries that presently have a predominance of emergency repair (Hungary, Finland, and Switzerland) have a higher proportion of elective repairs. As expected, the patients in these countries having a high proportion of emergency repair, also suffered a significantly higher risk of amputation, thus identifying an area of quality improvement.
Similar differences between countries were identified regarding the proportion of endovascular repair (Table 4). The highest proportion of endovascular repairs was found in Australia and Sweden. Countries with a high proportion of endovascular repair often also had a high incidence of operations per million inhabitants (Tables 2 and 3), and we have speculated that this trend might be explained by operating on older patients with endovascular techniques rather than open surgery. This does not seem to be the case, however: Australia has a median age of 74 years, but in Sweden the median is only 69 years, compared with the average of 70 years. It seems that the choice of surgical technique is more a result of surgical tradition than differences in case mix. Interestingly, the overall proportion of endovascular repairs in the studied countries (22.2%) was quite similar to that reported from the USA in 2007 (23.6%).
10
These trends are similar to those in intact AAA repair, where we previously reported that Finland and Hungary had the lowest, and Australia and Sweden the highest, proportion of EVAR.
12
While we have multiple randomised trials guiding us in the choice of open or endovascular repair of AAA,24
, 25
, 26
, 27
there are no similar data on how to treat PA, yet the trends are similar. Thus, it seems that therapeutic tradition rather than evidence guides vascular surgeons. A randomised trial comparing the techniques is certainly warranted. That could also supply us with long-term follow-up, which is crucial to evaluate the two methods. In this investigation we had only short term follow-up, which showed no difference in results. As one of the concerns regarding the new endovascular technique is durability, adding long-term follow-up in the registry databases is of utmost importance.A potential limitation in all registry data is the risk of selection bias due to insufficient validity. Several of these participating registries have been extensively validated, however (D. Bergqvist, M. Björck, T. Lees, G. Menyhei, submitted).
28
, 29
, 30
The Swedvasc was specifically validated for PA operations. Among 717 primary operations for PA, 146 were found to have bilateral operations when the case records were scrutinised; of those, 141 (96.6%) had been registered.1
When the variables to be collected were decided upon (Table 1), decisions were based on those available in most of the registries. This analysis has shown that the registries need to be revised and collect more precise data on pathology, indication, treatment and outcome in the future, and those variables given in Table 6.
Table 6Suggested variables to be added to the vascular registries.
Pathology/indication | |
Diameter of the aneurysm | mm |
Thrombosis in the aneurysm | Yes/no |
Number of run-off vessels | 0–3 |
Treatment | |
Preoperative thrombolysis | Yes/no |
Perioperative thrombolysis | Yes/no |
Approach during open repair | Medial/posterior |
Fasciotomy | Yes/no |
Outcome at 30 days and 1 year | |
Patency | Yes/no |
Amputation | Yes/no |
Symptoms | Claudication/ulcer/gangrene |
Conclusions
In this analysis of contemporary PA repair in eight countries, a great variability in incidence of operations, indications for surgery, and choice of surgical technique was found. Those differences seem to be more a result of surgical tradition than of differences in case mix. The participating registries need to revise their variables to improve recording of the patients who undergo preoperative thrombolysis prior to definite surgical repair, and to introduce at least 1 year of follow-up in order to evaluate medium-term results.
Conflict of Interest
None.
Funding
None.
References
- Nationwide study of the outcome of popliteal artery aneurysms treated surgically.Br J Surg. 2007; 94: 970-977
- Surgical management of popliteal artery aneurysms: which factors affect outcomes?.J Vasc Surg. 2006; 43: 481-487
- Surgical treatment of popliteal artery aneurysms.Scand J Surg. 2004; 93: 57-60
- Popliteal aneurysms: a 10-year experience.Eur J Vasc Endovasc Surg. 1998; 16: 218-222
- Popliteal artery aneurysms.World J Surg. 1998; 22: 812-817
- A multicenter study of popliteal aneurysms. Joint Vascular Research Group.J Vasc Surg. 1994; 20: 171-177
- Outcomes of surgical management for popliteal artery aneurysms: an analysis of 583 cases.J Vasc Surg. 2008; 48: 845-851
- Risk of new aneurysms after surgery for popliteal artery aneurysm.Br J Surg. 2008; 95: 571-575
- Stent fractures in the Hemobahn/Viabahn stent graft after endovascular popliteal aneurysm repair.J Vasc Surg. 2010; 51: 1413-1418
- Endovascular versus open repair of popliteal artery aneurysms; outcomes in the US medicare population.Vasc Endovasc Surg. 2013; 47: 267-273
- Vascular registries join and create the common European dataset on AAA surgery.Eur J Vasc Endovasc Surg. 2007; 34: 257-259
- Treatment of abdominal aortic aneurysm in nine countries 2005–2009: a Vascunet report.Eur J Vasc Endovasc Surg. 2011; 42: 598-607
- Outcome following carotid endarterectomy: lessons learned from a large international vascular registry.Eur J Vasc Endovasc Surg. 2011; 41: 735-740
- Variation in clinical practice in carotid surgery in 9 countries 2005–2010. Lessons from VASCUNET and recommendations for the future of national clinical audit.Eur J Vasc Endovasc Surg. 2012; 44: 11-17
- International variations in infrainguinal bypass surgery – a VASCUNET report.Eur J Vasc Endovasc Surg. 2012; 44: 185-192
- The Swedish experience of screening for abdominal aortic aneurysm.J Vasc Surg. 2011; 53: 1164-1165
- Low prevalence of abdominal aortic aneurysm among 65-year old Swedish men indicates a change in the epidemiology of the disease.Circulation. 2011; 124: 1118-1123
- First-year results of a national abdominal aortic aneurysm. screening programme in a single centre.Br J Surg. 2012; 99: 73-77
- Implementation of National Health Service abdominal aortic aneurysm screening program in England.J Vasc Surg. 2013; 57: 1440-1445
- Falling rates of hospitalization and mortality from abdominal aortic aneurysms in Australia.J Vasc Surg. 2011; 53: 274-277
- Trends in incidence and mortality from abdominal aortic aneurysm in New Zealand.Br J Surg. 2011; 98: 645-651
- Pathophysiology of AAA: heredity vs environment.Prog Cardiovasc Dis. 2013; 56: 2-6
- Surgical technique and long-term results after popliteal artery aneurysm repair. Results from 717 operated legs.J Vasc Surg. 2007; 46: 236-243
- Endovascular aneurysm repair versus open repair in patients with abdominal aortic aneurysm (EVAR trial 1): randomised controlled trial.Lancet. 2005; 365: 2179-2186
- Two-year outcomes after conventional or endovascular repair of abdominal aortic aneurysms.N Engl J Med. 2005; 352: 2398-2405
- Final 12-year follow-up of surgery versus surveillance in the UK Small Aneurysm Trial.Br J Surg. 2007; 94: 702-708
- Immediate repair compared with surveillance of small abdominal aortic aneurysms.N Engl J Med. 2002; 346: 1437-1444
- External validation of the Swedvasc registry: a first-time individual cross-matching with the unique personal identity number.Eur J Vasc Endovasc Surg. 2008; 36: 705-712
- Results from the Australasian Vascular Surgical Audit: the inaugural year.ANZ J Surg. 2012; 82: 105-111
- Auditing a nationwide vascular registry – the 4-year Finnvasc experience. Finnvasc Study Group.Eur J Vasc Endovasc Surg. 1997; 14: 468-474
Article info
Publication history
Published online: November 27, 2013
Accepted:
October 28,
2013
Received:
August 13,
2013
Identification
Copyright
© 2013 European Society for Vascular Surgery. Published by Elsevier Inc.
User license
Creative Commons Attribution – NonCommercial – NoDerivs (CC BY-NC-ND 4.0) | How you can reuse
Elsevier's open access license policy

Creative Commons Attribution – NonCommercial – NoDerivs (CC BY-NC-ND 4.0)
Permitted
For non-commercial purposes:
- Read, print & download
- Redistribute or republish the final article
- Text & data mine
- Translate the article (private use only, not for distribution)
- Reuse portions or extracts from the article in other works
Not Permitted
- Sell or re-use for commercial purposes
- Distribute translations or adaptations of the article
Elsevier's open access license policy
ScienceDirect
Access this article on ScienceDirectRelated Articles
Comments
Commenting Guidelines
To submit a comment for a journal article, please use the space above and note the following:
- We will review submitted comments as soon as possible, striving for within two business days.
- This forum is intended for constructive dialogue. Comments that are commercial or promotional in nature, pertain to specific medical cases, are not relevant to the article for which they have been submitted, or are otherwise inappropriate will not be posted.
- We require that commenters identify themselves with names and affiliations.
- Comments must be in compliance with our Terms & Conditions.
- Comments are not peer-reviewed.